Microalbumin: Urinary Biomarker of Cardiovascular Risk Assessment

Authors

  • Tabassum Samad Registrar, Nephrology, BIRDEM General Hospital, Shahbag, Dhaka-1000
  • Wasim Md Mohosin ul Haque Associate Professor, Nephrology, BIRDEM General Hospital, Shahbag, Dhaka 1000

DOI:

https://doi.org/10.3329/birdem.v5i2.28388

Keywords:

Cardiovascular events, Microalbuminuria, Urinary biomarker

Abstract

Microalbuminuria is an early sign of vascular damage. Now-a-days it is considered as a predictor of worse outcome for both renal and cardiac patients. In this review we investigate the magnitude of relationship between microalbuminuria and incident coronary heart disease and mortality. Microalbuminuria is an independent predictor of coronary heart disease and all cause mortality. It is demonstrated that cardiovascular and renal risk is elevated even in the high normal range of microalbuminuria. Early detection of microalbuminuria, or therapies that prevent or delay the development of microalbuminuria, and all measures that prevent it, may help to prevent or delay cardiovascular events

Birdem Med J 2015; 5(2): 98-103

Downloads

Download data is not yet available.
Abstract
665
PDF
586

Author Biography

Tabassum Samad, Registrar, Nephrology, BIRDEM General Hospital, Shahbag, Dhaka-1000



Downloads

Published

2016-06-25

How to Cite

Samad, T., & Haque, W. M. M. ul. (2016). Microalbumin: Urinary Biomarker of Cardiovascular Risk Assessment. BIRDEM Medical Journal, 5(2), 98–103. https://doi.org/10.3329/birdem.v5i2.28388

Issue

Section

Review Articles